metricas
covid
Buscar en
Neurología
Toda la web
Inicio Neurología Safety of anti-CGRP monoclonal antibodies in patients with migraine during the C...
Journal Information

Statistics

Follow this link to access the full text of the article

Original article
Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications
Seguridad de los anticuerpos monoclonales anti-CGRP en pacientes con migraña durante la pandemia de COVID-19: implicaciones actuales y futuras
E. Caronnaa,b, V. José Gallardob, A. Alpuentea,b, M. Torres-Ferrusa,b, N.M. Sánchez-Mateoc, J. Viguera-Romerod, A.C. López-Velosoe, A. López-Bravof, A.B. Gago-Veigag, P. Irimia Sieirah, J. Porta-Etessami, S. Santos-Lasaosaj, P. Pozo-Rosicha,b,
Corresponding author
ppozo@vhebron.net

Corresponding author.
, Spanish CGRP-COVID Study Group
a Headache Unit, Neurology Department, Hospital Universitari Vall d’Hebron, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain
b Headache and Neurological Pain Research Group, Vall d’Hebron Research Institute, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain
c Headache Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
d Headache Unit, Neuroscience Department, Hospital Universitario Virgen Macarena, Sevilla, Spain
e Neurology Department, Hospital Universitario de Gran Canaria Dr. Negrín, Gran Canaria, Spain
f Neurology Department, Hospital Reina Sofia, Tudela, Spain
g Headache Unit, Neurology Department, Hospital Universitario de La Princesa & Instituto de Investigación Sanitaria de La Princesa, Madrid, Spain
h Neurology Department, Clinica Universidad de Navarra, Pamplona, Spain
i Department of Neurology, Institute of Neurosciences, Hospital Clínico San Carlos, IdISSC, Universidad Complutense de Madrid, Madrid, Spain
j Headache Unit, Neurology Department, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain
Ver más
Read
2974
Times
was read the article
713
Total PDF
2261
Total HTML
Share statistics
Article information
ISSN: 02134853
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 40 2 42
2024 October 39 13 52
2024 September 67 14 81
2024 August 63 17 80
2024 July 44 9 53
2024 June 45 7 52
2024 May 44 17 61
2024 April 59 7 66
2024 March 70 7 77
2024 February 76 12 88
2024 January 67 8 75
2023 December 47 9 56
2023 November 71 14 85
2023 October 69 11 80
2023 September 30 5 35
2023 August 34 15 49
2023 July 33 8 41
2023 June 52 5 57
2023 May 34 14 48
2023 April 28 7 35
2023 March 22 14 36
2023 February 32 6 38
2023 January 21 5 26
2022 December 27 17 44
2022 November 34 15 49
2022 October 35 14 49
2022 September 35 15 50
2022 August 35 16 51
2022 July 27 9 36
2022 June 35 16 51
2022 May 26 13 39
2022 April 49 17 66
2022 March 67 14 81
2022 February 52 11 63
2022 January 60 18 78
2021 December 75 22 97
2021 November 122 40 162
2021 October 376 55 431
2021 September 20 23 43
2021 August 13 33 46
2021 July 22 20 42
2021 June 16 9 25
2021 May 19 28 47
2021 April 29 82 111
Show all

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos